PN
Pramod Nagorao Chede
About Pramod Nagorao Chede
Data last updated:
Pramod Nagorao Chede was an Additional Director at Genekon Pharmaceutical Private Limited (2020–2026), Designated Partner at Florenova Medisciences Llp (2025–2026) and Director at Being Innovation Private Limited (2019–2026), and held 1 more directorship. The companies operate in Pharma, Business Services and Healthcare.
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Genekon Pharmaceutical Private Limited U24100MH2015PTC265790 | Additional Director | 09 Nov 2020 | 2015 | Active | |
| Florenova Medisciences Llp ACO-3944 | Designated Partner | 15 May 2025 | 2025 | Active | |
| Being Innovation Private Limited U74999DL2018PTC340400 | Director | 16 Feb 2019 | 2018 | Active | |
| Medinine Hospital Llp ABA-5458 | Partner | 08 Feb 2022 | 2022 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Pramod Nagorao Chede
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pramod Nagorao Chede
Pramod Nagorao Chede was first appointed on 16 Feb 2019 as Director at Being Innovation Private Limited. The most recent appointment on record is 15 May 2025 at Florenova Medisciences Llp.
Pramod Nagorao Chede held 4 earlier board appointments: Genekon Pharmaceutical Private Limited (Additional Director, 09 Nov 2020 to 02 Feb 2026); Florenova Medisciences Llp (Designated Partner, 15 May 2025 to 02 Feb 2026); Being Innovation Private Limited (Director, 16 Feb 2019 to 02 Feb 2026); Medinine Hospital Llp (Partner, 08 Feb 2022 to 10 Jan 2024).